This site is intended for healthcare professionals only
LoginRegister
CDSCO panel rejects Pfizer Products India Local Clinical Trial Waiver Proposal for Elranatamab solution for injectionCDSCO panel rejects Pfizer Products India Local Clinical Trial Waiver Proposal for Elranatamab...
Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans AppealUSFDA nod to Pfizer Beqvez for adults with Hemophilia B
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresZydus Lifesciences bags USFDA nod for acne cream Tretinoin
Intas PharmaIntas Pharmaceuticals Gets CDSCO Panel Nod to Study Trastuzumab Emtansine in Metastatic Breast...
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca Voydeya approved in EU as add-on treatment to ravulizumab or eculizumab for adults with...
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyNestle India, Dr Reddy's to form JV to bring nutraceutical brands to consumers in India, other...
Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans AppealPfizer Emblaveo gets European Commission marketing nod for patients with multidrug-resistant...
Lupin and TB Alliance Join Forces to Advance TelacebecLupin bags USFDA approval for Loteprednol Etabonate Ophthalmic Suspension
Eli Lilly Announces USD 3.5 Billion US Manufacturing Facility for Next-Gen Obesity DrugsEli Lilly Gets CDSCO Panel Nod to Study Lepodisiran
Granules India packaging facility in US successfully completes USFDA inspectionNatco Pharma gets USFDA EIR on pharmacovigilance requirements
Lupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million MarketLupin Digital Health's Lyfe Platform gets Class C Medical Device license from CDSCO
India targets new markets for pharma export growth amid US tariffs concernsIndian pharma exports increase 10 percent to USD 27.9 billion in FY24
X